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In this issue, Schulte et al. (2008) present the structure of the N-terminal region of human Diaphanous-related
formin FHOD1, providing new insights into the differential molecular mechanisms of formin regulation and
activity.Tight control and regulation of cytoskele-
tal rearrangements is one of the great
challenges that a cell has to face in the es-
tablishment of fundamental cellular pro-
cesses such as cell motility, cytokinesis,
and morphogenesis. Over the past few
years, the family of formins has emerged
asadiversegroupofmultidomainproteins
that contains a unique actin binding formin
homology 2 (FH2) domain. Catalytic activ-
ity of the FH2 domain intertwines these
proteins with different aspects of actin cy-
toskeleton dynamics and the consecutive
transmission of extracellular signals to
transcriptional programs driven mainly
by the serum response factor (SRF) (Faix
and Grosse, 2006). By forming a tethered
dimer, the FH2 domains promote barbed
end actin polymerization (Otomo et al.,
2005b; Xu et al., 2004) and may also lead
to the formation of higher order actin
structures through the bundling of preex-
isting filaments (Harris et al., 2006).
FHOD1 belongs to the subfamily of Di-
aphanous-related formins (DRFs), which
have been shown to act as effectors of
GTPases of the Rho family. DRFs are char-
acterized by the formation of a basal state
of autoinhibition,which isachievedby intra-
molecular interaction between the C-termi-
nal Diaphanous autoregulatory domain
(DAD) and the FH3 domain, which, in coop-
eration with a GTPase binding domain
(GBD), forms an N-terminal array of regula-
tory sequences (Figure 1A). In the case of
a prototypic formin, mDia1, structural and
functional evidence exists that autoinhibi-
tion can be relieved after binding of an ac-
tive Rho GTPase to the GBD (Brandt et al.,
2007; Lammers et al., 2005; Otomo et al.,
2005a), whereas additional signals may be
required for full activity of some DRFs. Fur-
ther characterization of DRF specificity for
different Rho GTPases has led to the delin-
eation of specific subsets of DRF/GTPase
modules, underlining the fundamental roleof the GBD architecture in maintaining
a well-defined balance in the complexity
of formin-mediated signaling events.
Previous structural analysis of the FH2
domain of yeast Bni1p (Otomo et al.,
2005b; Xu et al., 2004), aswell as structure
determinations of the mDia1 N-terminal
regulatory region, (Lammers et al., 2005;
Nezami et al., 2006; Otomo et al., 2005a)
have led to decisive progress in the field
and significantly affected our present un-
derstanding of formin function and their
sophisticated regulation. However, based
on low sequence similarities, it is imma-
nent that the structure and function of
the various Diaphanous-related formins
cannot be generalized and structure pre-
dictions so far often fail to decipher the
GBD and FH3 domains in given DRFs.
So how do you find a GBD that is hiding
away? Schulte et al. (2008) set out to shed
some light on this subject by solving the
crystal structureof theN terminusofmam-
malian FHOD1, which was a previously
unknown region. Unexpectedly, they
identified two domains with a GBD that is
structurally unrelated to the common
GBDs of formins. Very much in line, how-
ever, with the domain architecture and
structure of the prototypic formin mDia1
is the adjacent FH3 domain of FHOD1
that is composed of five armadillo repeats
that provide the surface for intramolecular
interactionwith theDAD (Figure 1B).Using
domain superimposition with the mDia1
FH3 domain, they could identify a valine
at position 228 that, when mutated to glu-
tamate, would disrupt autoinhibition as
analyzed by functional assays. However,
a real surprise was around the corner
when they took a closer look at the domain
N-terminal of the armadillo repeats.
Schulte et al. (2008) found that this domain
contains a b sheet that reveals an ubiquitin
superfold very similar to that of the Ras-
binding domain of c-Raf1. This suggestedStructure 16, September 10, 2008to them that they were looking at the GBD
of FHOD1. Interestingly, thedeletion of the
GBD did not result in a constitutive active
mutant, as implicated by other studies of
DRFs. In fact, in the case of FHOD1, its
cellular biological activity was lost in mu-
tants lacking the GBD, suggesting that
this domain is essential for its effects on
actin assembly in vivo. Nevertheless, this
domain is indeed a GBD, as directly
demonstrated by activated Ras using
isothermal titration calorimetry (ITC) ex-
periments. In addition, by screening 33
GTPases of the Ras superfamily for their
ability to recruit FHOD1 to the cell cortex,
the authors found that only Rac efficiently
relocalized FHOD, although some activity
with Ras was also detected. Thus, the
formin FHOD1may be involved in Rac sig-
naling as expected from previous studies
(Westendorf, 2001) but also appears as
a candidate effector molecule for Ras.
Several interesting questions obviously
arise from these findings. What has Ras
got to dowith it? Asmentioned earlier, for-
mins are potent regulators of actin fila-
ment assembly, functions that have not
been directly linked with Ras. Ras is well
known for its effects on cell proliferation
and transformation. Interestingly, these
functions require a balanced crosstalk be-
tween Ras and Rho signaling. An interest-
ing possibility is that FHOD1 integrates
aspects of these pathways.
Another central question remains: how
does the recruitment through Rac-
GTPases, proteins that are involved in
cell spreading and lamellipodia formation,
fit with the counteractive biological acti-
vity of FHOD1 exerted on stress fibers
and actin bundling, which involves the
recently reported phosphorylation-activa-
tion mechanism by Rho kinase (ROCK)
(Hannemann et al., 2008; Takeya et al.,
2008)? Could FHOD1 function as a scav-
enger for active Rac, while being recruitedª2008 Elsevier Ltd All rights reserved 1287
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PreviewsFigure 1. Integrated Model of Domain Organization, Molecular Regulation, and N-Terminal
Structure of Human FHOD1
(A) Schematic representation of the proposed domain architecture of human FHOD1 in the context of
autoinhibition and successive relieve, respectively. Abbreviations: GBD: GTPase binding domain; FH3:
formin homology 3 domain; FH1: formin homology 1 domain; FH2: formin homology 2 domain; DAD:
Diaphanous autoregulation domain. Numbers indicate amino acid positions. The latent state, characterized
by DAD-FH3 interaction (dashed line), is relieved by ROCK-induced phosphorylations at indicated resi-
dues within the DAD (Takeya et al., 2008) that are accompanied by binding of activated GTPases (Rac,
Ras) to the GBD, causing subcellular localization of FHOD1. Hence, the exposed catalytic FH2 domain
is capable of exerting effects on the actin cytoskeleton and subsequently affects transcriptional activity
of the serum response factor (SRF).
(B) Ribbon/surface representation of the overall structure of FHOD1 N-terminal sequences (amino acids
14-339). The N-terminal GBD (green) reveals a ubiquitin superfold and comprises a long loop (residues
24-41), which allows the insertion of a phenylalanine (F29) into the adjacent FH3 domain. The FH3 domain
(purple) provides the DAD interaction surface with valine 228 as a key residue for maintenance of autoin-
hibition.1288 Structure 16, September 10, 2008 ª2008 Elsevier Ltd All rights reservedto the plasmamembrane for phosphoryla-
tion through ROCK? In such a scenario,
localized Rho/ROCK activity may be fine-
tuned or amplified by simultaneous inhibi-
tionofRac.Clearly, FHOD1doesnot fit our
current view of formin regulation, suggest-
ing that, with over 14 formins known in
humans, there are many more surprises
tobeunveiled. It is thusbecoming increas-
ingly evident that many formins may exert
important functions beyond their actin-
assembling properties.
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